Related Experiment Video
Updated: Feb 11, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.5K
A Raf-Competitive K-Ras Binder Can Fail to Functionally Antagonize Signaling
Monique J Kauke1,2, Alison W Tisdale2,3, Ryan L Kelly2,3
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Molecular Cancer Therapeutics
|May 4, 2018
Summary
A K-Ras antagonist (R11.1.6) did not inhibit cancer cell signaling or proliferation, despite binding Ras. This suggests high concentrations are needed to overcome cellular barriers for effective Ras-targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ras GTPases are key drivers in ~30% of human cancers, leading to therapy resistance.
- Directly targeting Ras has been a long-standing challenge in cancer drug development.
Purpose of the Study:
- To evaluate the efficacy of a K-Ras antagonist (R11.1.6) in inhibiting Ras signaling and cancer cell proliferation.
- To understand the molecular mechanisms underlying the antagonist's biological effects.
Main Methods:
- Generated cancer cell lines expressing R11.1.6 via lentiviral transduction.
- Confirmed R11.1.6 binding to endogenous Ras using microscopy and co-immunoprecipitation.
- Quantified R11.1.6 expression levels and developed a mathematical model for Ras-R11.1.6-Raf binding.
Main Results:
- R11.1.6 specifically bound to endogenous Ras in engineered cell lines.
- Intracellular expression of R11.1.6 did not inhibit MAPK or PI3K signaling pathways.
- Cellular proliferation remained unaffected by R11.1.6 expression.
Conclusions:
- Stoichiometric and thermodynamic barriers may prevent R11.1.6 from effectively inhibiting Ras signaling.
- Future pharmacologic strategies require overcoming high effective concentrations of downstream effectors at the cell membrane.
Related Concept Videos
02:34Competition
24.9K
When organisms require the same limited resources within an environment, they may have to compete for them. Competition is a net-negative interaction. Even if two competing individuals or populations do not interact directly, the overall fitness of both competitors is lowered as a result of not having full access to the limited resource.
24.9K
02:38The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
01:14Agonism and Antagonism: Quantification
1.1K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.1K
01:17Hypothesis: Accept or Fail to Reject?
29.6K
The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.6K
01:24Small GTPases - Ras and Rho
5.5K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.5K
01:30Combined Effects of Drugs: Antagonism
11.8K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K